Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse-Reference-Cited by-同舟云学术

Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse

Published:2022-11 Issue:11 Volume:25 Page:105430
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Lorenzo Guillermo,di Muzio Nadia,Deantoni Chiara Lucrezia,Cozzarini Cesare,Fodor Andrei,Briganti Alberto,Montorsi Francesco,Pérez-García Víctor M.,Gomez Hector,Reali Alessandro

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference87 articles.

1. Molecular Biology of the Cell;Alberts,2007

2. Tumor-immune ecosystem dynamics define an individual radiation immune score to predict pan-cancer radiocurability;Alfonso;Neoplasia,2021

3. Optimal combinations of chemotherapy and radiotherapy in low-grade gliomas: a mathematical approach;Ayala-Hernández;J. Personalized Med.,2021

4. PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy;Bates;Int. J. Radiat. Oncol. Biol. Phys.,2005

5. Prognostic role of Ki-67 score in localized prostate cancer: a systematic review and meta-analysis;Berlin;Urol. Oncol.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Specific, Mechanistic Models of Tumor Growth Incorporating Artificial Intelligence and Big Data;Annual Review of Biomedical Engineering;2024-07-03

2. Mathematical modeling of brain metastases growth and response to therapies: A review;Mathematical Biosciences;2024-07

3. Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA;JCO Clinical Cancer Informatics;2024-03

4. A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model;Cancer Research Communications;2024-03-01

5. Designing clinical trials for patients who are not average;iScience;2024-01